title: Up-regulation of oxytocin receptors in rabbit amnion by glucocorticoids: potentiation by cyclic adenosine 3',5'-monophosphate.
abstract: Oxytocin (OT) receptors (OTR) in rabbit amnion increase more than 200-fold at the end of gestation. In the present report, we studied the basis of this up-regulation. Incubation of amnion cells with cortisol (20 nM) for 24 h increased the amount of 125I-labeled OT antagonist bound by 16- to 18-fold. The effects of cortisol were dose and steroid dependent. Administration of glucocorticoid to pregnant does also increased the concentration of OTRs in amnion. The effects of cortisol in vitro were potentiated by the addition of forskolin (50 microM), so that OTR number increased by as much as 182 times. The effects of cortisol and forskolin, either separately or in combination, were inhibited by activation of protein kinase-C or coincubation with transforming growth factor-alpha (10 nM). Cyclosporin-A (5 microM) selectively inhibited cortisol-induced rises in the OTR concentration. The addition of cortisol to amnion cells increased OT-stimulated prostaglandin E2 (PGE2) release almost 100-fold; the combination of forskolin and cortisol increased the PGE2 response to OT about 5600 times. Judging from the greater effects on PGE2 release, these results suggest that forskolin and cortisol up-regulate the signal response mechanism to OT as well as the OTR concentration. The findings show that changes occurring in the amnion in vivo can be mimicked in vitro, and they elucidate the mechanism of up-regulation of OTR concentrations.
authors.affiliation: Department of Surgery, Medical College of Ohio, Toledo 43699-1008.
authors.forename: A
authors.initials: A
authors.lastname: Hinko
authors.forename: M S
authors.initials: MS
authors.lastname: Soloff
mesh_terms: D000650:Amnion / Q000166:cytology / Q000378:metabolism*; D000818:Animals; D002478:Cells, Cultured; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology*; D015232:Dinoprostone / Q000378:metabolism; D004357:Drug Synergism; D005938:Glucocorticoids / Q000494:pharmacology*; D006854:Hydrocortisone / Q000494:pharmacology; D007425:Intracellular Membranes / Q000378:metabolism; D010121:Oxytocin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011817:Rabbits; D018045:Receptors, Oxytocin / Q000378:metabolism*; D016211:Transforming Growth Factor alpha / Q000494:pharmacology; D015854:Up-Regulation
chemical_list: D005938:Glucocorticoids; D018045:Receptors, Oxytocin; D016211:Transforming Growth Factor alpha; D005576:Colforsin; D010121:Oxytocin; D000242:Cyclic AMP; D015232:Dinoprostone; D006854:Hydrocortisone